Pentoxifylline (Mylan Institutional Inc.)
Welcome to the PulseAid listing for the Pentoxifylline drug offered from Mylan Institutional Inc.. This Blood Viscosity Reducer [EPC],Hematologic Activity Alteration [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Mylan Institutional Inc. |
| NON-PROPRIETARY NAME: | Pentoxifylline |
| SUBSTANCE NAME: | PENTOXIFYLLINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Blood Viscosity Reducer [EPC],Hematologic Activity Alteration [PE] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED, EXTENDED RELEASE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 1998-01-15 |
| END MARKETING DATE: | 0000-00-00 |
Pentoxifylline HUMAN PRESCRIPTION DRUG Details:
| Item Description | Pentoxifylline from Mylan Institutional Inc. |
| LABELER NAME: | Mylan Institutional Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 400(mg/1) |
| START MARKETING DATE: | 1998-01-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 51079-889_6b9a9221-bddb-41f6-9f25-afa77d22f00d |
| PRODUCT NDC: | 51079-889 |
| APPLICATION NUMBER: | ANDA074425 |
Other PENTOXIFYLLINE Pharmaceutical Manufacturers / Labelers:
